European Symposium on Precision Medicine in Allergy and Airways Diseases: Report of the European Union Parliament Symposium (October 14, 2015)

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 5, 2016, Pages 583-587

  Muraro, A ^a   Fokkens, W J ^b   Pietikainen, S ^c   Borrelli, D ^c   Agache, I ^d   Bousquet, J ^e   Costigliola, V ^f   Joos, G ^g   Lund, V J ^b   Poulsen, L K ^a   Price, D ^h   Rolland, C ⁱ   Zuberbier, T ^j   Hellings, P W ^a  

^a European Academy of Allergy and Clinical Immunology (EAACI)   (Germany)

^b European Rhinologic Society (ERS)   (Germany)

^c Interest Group on Allergy and Asthma of the European Parliament   (Finland)

^d TRANSILVANIA UNIVERSITY OF BRASOV   (Romania)

^e Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing   (Romania)

^f European Medical Association (EMA)   (Romania)

^g European Respiratory Society (ERS)   (Romania)

^h Respiratory Effectiveness Group (REG)   (Romania)

ⁱ European Federation of Allergy and Asthma Patients Organisations (EFA)   (Romania)

^j Global Allergy and Asthma European Network (Ga2len)   (Romania)

more..

Author keywords

airways diseases; allergy; personalized care; precision medicine; prevention

Indexed keywords

ALLERGY; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; EUROPE; EUROPEAN UNION; HUMAN; IMMUNOTHERAPY; NOTE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RHINITIS; RHINOSINUSITIS; CHRONIC DISEASE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HYPERSENSITIVITY; INTERNATIONAL COOPERATION; PROCEDURES;

CHRONIC DISEASE; DELIVERY OF HEALTH CARE; EUROPE; HUMANS; HYPERSENSITIVITY; INTERNATIONAL COOPERATION; PRECISION MEDICINE; REGIONAL HEALTH PLANNING; RESPIRATORY TRACT DISEASES;

EID: 84959929607     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12819     Document Type: Note

References (30)

1. EAACI Global Atlas of Allergy. http://www.eaaci.org/globalatlas/GlobalAtlasAllergy.pdf [Internet]. [cited 2015 Nov 26]. Available from: http://www.eaaci.org/globalatlas/GlobalAtlasAllergy.pdf
2. EAACI Global Atlas on Asthma. http://www.eaaci.org/attachments/Global%20Atlas%20of%20Asthma.pdf [Internet]. [cited 2015 Nov 26]. Available from: http://www.eaaci.org/attachments/GlobalAtlasofAsthma.pdf
3. Global Atlas of Allergic Rhinitis and Chronic Rhinosinusitis. http://eaaci.org/resources/scientific-output/global-atlas-of-allergic-rhinitis-and-chronic-rhinosinusitis.html [Internet]. [cited 2015 Nov 26]. Available from: http://eaaci.org/globalatlas/ENT-Atlas-web.pdf
4. Bousquet JKN,. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases. A Comprehensive Approach. Global Alliance Against Chronic Respiratory Diseases. World Health Organization. ISBN 978 92 4 156346 8. 2007:148 pages. [Internet]. [cited 2015 Nov 26]. Available from: http://www.who.int/gard/publications/GARDBook2007.pdf
5. Samoliński B, Fronczak A, Kuna P, Akdis CA, Anto JM, Bialoszewski AZ, et al., Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy 2012; 67: 726-731.
6. Collins FS, Varmus H,. A new initiative on precision medicine. N Engl J Med 2015; 372: 793-795.
7. Canonica GW, Bachert C, Hellings P, Ryan D, Valovirta E, Wickman M, et al., Allergen Immunotherapy (AIT): a prototype of Precision Medicine. World Allergy Organ J 2015; 8: 31.
8. Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, et al., MACVIA-ARIA Sentinel Network for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy 2015; 70: 1372-1392.
9. Bieber T,. Stratified Medicine: A New Challenge for Academia, Industry, Regulators and Patients. In: Bieber T, editor. London: Future Medicine Ltd, 2013: 75 pp.
10. Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al., Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 2014; 44: 304-323.
11. Bousquet J, Michel J-P, Strandberg T, Crooks G, Iakovidis I, Iglesia M,. The European Innovation Partnership on Active and Healthy Ageing: The European Geriatric Medicine Introduces the EIP on AHA Column. Eur Geriatr Med 2014; 5: 361-362.
12. Deliu M, Belgrave D, Simpson A, Murray CS, Kerry G, Custovic A,. Impact of rhinitis on asthma severity in school-age children. Allergy 2014; 69: 1515-1521.
13. Agache I, Sugita K, Morita H, Akdis M, Akdis CA,. The complex type 2 endotype in allergy and asthma: from laboratory to bedside. Curr Allergy Asthma Rep 2015; 15: 29.
14. Morais-Almeida M, Pite H, Pereira AM, Todo-Bom A, Nunes C, Bousquet J, et al., Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal. Allergy 2013; 68: 1150-1157.
15. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al., Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 (Suppl. 8): 8-160.
16. Hellings PW, Fokkens WJ, Akdis C, Bachert C, Cingi C, Dietz de Loos D, et al., Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy 2013; 68: 1-7.
17. Vuurman EFPM, Vuurman LL, Lutgens I, Kremer B,. Allergic rhinitis is a risk factor for traffic safety. Allergy 2014; 69: 906-912.
18. Vandenplas O, D'Alpaos V, Van Brussel P,. Rhinitis and its impact on work. Curr Opin Allergy Clin Immunol 2008; 8: 145-149.
19. Muraro A, Clark A, Beyer K, Borrego LM, Borres M, Lødrup Carlsen KC, et al., The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school. Allergy 2010; 65: 681-689.
20. Zuberbier T, Lötvall J, Simoens S, Subramanian SV, Church MK,. Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review. Allergy 2014; 69: 1275-1279.
21. Prokopakis EP, Vlastos IM, Ferguson BJ, Scadding G, Kawauchi H, Georgalas C, et al., SCUAD and chronic rhinosinusitis. Reinforcing hypothesis driven research in difficult cases. Rhinology 2014; 52: 3-8.
22. EAACI Strategic Program-2015-2017. http://www.eaaci.org/organisation/eaaci-strategic-programme/2013-2015.html [Internet]. [cited 2015 Nov 26]. Available from: http://www.eaaci.org/organisation/eaaci-strategic-programme/2013-2015.html
23. Bousquet J, Anto JM, Wickman M, Keil T, Valenta R, Haahtela T, et al., Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis. Allergy 2015; 70: 1062-1078.
24. Ardern-Jones MR, Bieber T,. Biomarkers in atopic dermatitis: it is time to stratify. Br J Dermatol 2014; 171: 207-208.
25. Alvarado MI, Jimeno L, De La Torre F, Boissy P, Rivas B, Lázaro MJ, et al., Profilin as a severe food allergen in allergic patients overexposed to grass pollen. Allergy 2014; 69: 1610-1616.
26. Moreno C, Justicia JL, Quiralte J, Moreno-Ancillo A, Iglesias-Cadarso A, Torrecillas M, et al., Olive, grass or both? Molecular diagnosis for the allergen immunotherapy selection in polysensitized pollinic patients. Allergy 2014; 69: 1357-1363.
27. Van Gerven L, Boeckxstaens G, Jorissen M, Fokkens W, Hellings PW,. Short-time cold dry air exposure: a useful diagnostic tool for nasal hyperresponsiveness. Laryngoscope 2012; 122: 2615-2620.
28. Haahtela T, von Hertzen L, Mäkelä M, Hannuksela M,. Finnish Allergy Programme 2008-2018-time to act and change the course. Allergy 2008; 63: 634-645.
29. Jameson JL, Longo DL,. Precision medicine-personalized, problematic, and promising. N Engl J Med 2015; 372: 2229-2234.
30. Bieber T,. Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine. Allergy 2012; 67: 1475-1482.